Papadopoulos KP, Autio K, Golan T, Dobrenkov K, et al. Phase I Study of MK-4166, an Anti-human Glucocorticoid-Induced TNF Receptor Antibody, Alone or with Pembrolizumab in Advanced Solid Tumors. Clin Cancer Res 2021;27:1904-1911.
PMID: 33355238